Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-1299PMID 16424049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD4+ Tregs and immune control.

  2004cited by this paper
• Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity

  2004cited by this paper
• Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7

  2004cited by this paper
• Derangement of immune responses by myeloid suppressor cells

  2004cited by this paper
• Immunoregulatory T cells in tumor immunity.

  2004cited by this paper
• Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species1

  2004cited by this paper
• Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.

  2004cited by this paper
• Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance.

  2004cited by this paper
• TGF‐β Induces Foxp3 + T‐Regulatory Cells from CD4 + CD25 − Precursors

  2004cited by this paper
• IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice1

  2003cited by this paper
• Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3

  2003cited by this paper
• Increase of regulatory T cells in the peripheral blood of cancer patients.

  2003cited by this paper
• Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens.

  2003cited by this paper
• L-arginine metabolism in myeloid cells controls T-lymphocyte functions.

  2003cited by this paper
• Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning.

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease.

  2003cited by this paper
• Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.

  2003cited by this paper
• l-Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes1

  2003cited by this paper
• Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10.

  2003cited by this paper
• Supporting Online Material

  2002cited by this paper
• Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells

  2002cited by this paper
• OX40 ligation enhances primary and memory cytotoxic T lymphocyte responses in an immunotherapy for hepatic colon metastases.

  2002cited by this paper
• Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1

  2001cited by this paper
• Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1

  2001cited by this paper
• Interleukin‐10 expressed at early tumour sites induces subsequent generation of CD4+ T‐regulatory cells and systemic collapse of antitumour immunity

  2001cited by this paper
• Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

  2001cited by this paper
• Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

  2001cited by this paper
• Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

  2001cited by this paper
• Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation1

  2000influential reference
• PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation.

  1999influential reference
• Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.

  1999cited by this paper
• Immunologic nonresponsiveness to tumors.

  1998cited by this paper
• The Orphan Receptor CRF2-4 Is an Essential Subunit of the Interleukin 10 Receptor

  1998cited by this paper
• Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

  1998cited by this paper
• A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

  1997cited by this paper
• Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.

  1997cited by this paper
• Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.

  1996cited by this paper
• Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.

  1996cited by this paper
• Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity.

  1996cited by this paper
• Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-gamma.

  1995cited by this paper
• Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

  1995cited by this paper
• Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

  1994cited by this paper
• The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR.

  1994cited by this paper
• T-cell subsets and suppressor cells in human bone marrow.

  1992cited by this paper
• Natural suppressor cells.

  1989cited by this paper
• Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.

  1987cited by this paper
• Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.

  1975cited by this paper
• Transforming Growth Factor-␤ Production and Myeloid Cells Are an Effector Mechanism through Which Cd1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance: Abrogation Prevents Tumor Recurrence

  year unknowncited by this paper

• Deficiency of SMARCB1 drives an immunosuppressive microenvironment in meningioma

  2026cites this paper
• Myeloid-derived suppressor cells and regulatory T cells in colorectal cancer: a synergistic immunosuppressive axis and emerging therapeutic opportunities

  2026cites this paper
• Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis.

  2026cites this paper
• APX3330 reverses the immunosuppressive tumor microenvironment during colorectal carcinogenesis

  2026cites this paper
• Neuroimmune Mechanisms in Traumatic Brain Injury and Cancer: Parallel Courses or Existence in Different Orbits

  2026cites this paper
• The Role of Macrophages in Cancer: From Basic Research to Clinical Applications

  2025cites this paper
• The impact of multidimensional interactions among Helicobacter pylori infection, tumor microenvironment, and gut microbiota on gastric cancer immune response.

  2025cites this paper
• Tumor cell-derived microparticles containing MTX (MTX-TMPs) in the treatment of cholangiocarcinoma by modulating MDSCs.

  2025cites this paper
• The myeloid switch: immune drivers in atopic dermatitis — roles in pathogenesis and emerging therapeutic targeting

  2025cites this paper
• Multi-omics dissection of tumor microenvironment-mediated drug resistance: mechanisms and therapeutic reprogramming

  2025cites this paper
• Emerging Role of MDSCS as Novel Biomarkers and Therapeutic Targets for Cancer Immunotherapy

  2025influential citation
• Pan-Cancer Single-Cell RNA Sequencing Analysis Refines Multi-Origin Monocyte and Macrophage Lineages

  2025cites this paper
• Механизмы резистентности к иммунотерапии при MSI фенотипе

  2025cites this paper
• Immunotherapy for high-grade endometrial stromal sarcoma: a narrative review bridging molecular insights to clinical translation

  2025cites this paper
• A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors.

  2025cites this paper
• The important role of myeloid-derived suppressor cells: From hepatitis to liver cancer.

  2025cites this paper
• The role of myeloid-derived suppressor cells in children

  2025cites this paper
• USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells

  2025cites this paper
• The Black Hole of Immune Checkpoint Blocking Therapy for Gastric Cancer: Hyperprogressive Disease

  2025cites this paper
• Harnessing myeloid cells in cancer

  2025cites this paper
• Modulating the CXCR2 Signaling Axis Using Engineered Chemokine Fusion Proteins to Disrupt Myeloid Cell Infiltration in Pancreatic Cancer

  2025cites this paper
• Innate Immunity and Platelets: Unveiling Their Role in Chronic Pancreatitis and Pancreatic Cancer

  2025cites this paper
• Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy

  2025cites this paper
• Myeloid Specific Ablation of SHIP1 Boosts ex vivo Expansion and Regulatory Function of Myeloid-Derived Suppressor Cells in Inflammatory Arthritis

  2025cites this paper
• Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis

  2025cites this paper
• The Significance of the Microenvironment in T/Nk-Cell Neoplasms

  2025cites this paper
• Extracellular Vesicle-Based Strategies for Tumor Immunotherapy

  2025cites this paper
• Impact of Reduction in Myeloid‐derived Suppressor Cells by Wilms’ Tumor 1‐targeted Dendritic Cell Vaccines on Clinical Outcomes in Acute Leukemia Patients

  2025cites this paper
• Advances in nanomedicine strategies for modulating the tumor microenvironment: Recent progress and clinical perspectives

  2025cites this paper
• EFFECT OF CALCITRIOL ON MYELOID-DERIVED SUPPRESSOR CELLS IN PHYSIOLOGICAL AGING.

  2025cites this paper
• The potential application of stroma modulation in targeting tumor cells: focus on pancreatic cancer and breast cancer models.

  2025cites this paper
• Modulation of tumor inflammatory signaling and drug sensitivity by CMTM4

  2025cites this paper
• Research Progress of Dendritic Cell Subpopulations and Their Dysfunction in the Tumor Microenvironment

  2025cites this paper
• Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma

  2025cites this paper
• Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy.

  2025cites this paper
• Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy

  2025cites this paper
• Myeloid-derived suppressor cell inhibits T-cell-based defense against Klebsiella pneumoniae infection via IDO1 production

  2025cites this paper
• Systemic inflammation in response to radiation drives the genesis of an immunosuppressed tumor microenvironment

  2025cites this paper
• The impact of cytokines and tumour‐conditioned medium on the properties of murine in vitro generated myeloid‐derived suppressor cells

  2025cites this paper
• Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets

  2025cites this paper
• Regulatory T cells poise the myeloid landscape after chemotherapy in lung tumors.

  2025cites this paper
• Drug resistance in TKI therapy for hepatocellular carcinoma: mechanisms and strategies.

  2025cites this paper
• Spatially resolved whole-transcriptomic profiling of EGFR-mutated lung adenocarcinomas stratified by PD-L1 expression

  2025cites this paper
• Effective suppression of tumor growth and hepatic metastasis of neuroblastoma by NKT-stimulatory phenyl glycolipid.

  2024cites this paper
• How modulation of the tumor microenvironment drives cancer immune escape dynamics

  2024cites this paper
• Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade

  2024cites this paper
• Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism

  2024cites this paper
• Interactions between fibroblasts and monocyte-derived cells in chronic lung injuries induced by real-ambient particulate matter exposure.

  2024cites this paper
• Emergency myelopoiesis in solid cancers

  2024cites this paper
• Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression

  2024cites this paper
• MDSCs use a complex molecular network to suppress T-cell immunity in a pulmonary model of fungal infection

  2024cites this paper
• Bexarotene Induce Differentiation of Myeloid-Derived Suppressor Cells through Arg-1 Signalling Pathway.

  2024cites this paper
• Immunosuppressive regulatory cells in cancer immunotherapy: restrain or modulate?

  2024cites this paper
• Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)

  2024cites this paper
• Immune Cell Migration to Cancer

  2024cites this paper
• Role of angiotensin converting enzyme in pathogenesis associated with immunity in cardiovascular diseases.

  2024cites this paper
• IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma.

  2024cites this paper
• Proliferation of MDSCs may indicate a lower CD4+ T cell immune response in schistosomiasis japonica

  2024cites this paper
• The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy.

  2024cites this paper
• The impact of IL‐10 and IL‐17 on myeloid‐derived suppressor cells in vitro and in vivo in a murine model of asthma

  2024cites this paper
• Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion

  2024cites this paper
• Effects of chronic stress on cancer development and the therapeutic prospects of adrenergic signaling regulation.

  2024cites this paper
• Insights into the management of penile squamous cell carcinoma: from conventional approaches to emerging novel therapies

  2024cites this paper
• Pivotal role of myeloid‐derived suppressor cells in infection‐related tumor growth

  2024cites this paper
• Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

  2024cites this paper
• The role of tumor-associated macrophages in tumor immune evasion

  2024cites this paper
• Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

  2024cites this paper
• High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP

  2024cites this paper
• Prognostic role of circulating cytokines and inflammation indexes for avelumab maintenance in metastatic urothelial carcinoma

  2024cites this paper
• MDSC-targeted liposomal all-trans retinoic acid suppresses mMdscs and improves immunotherapy in HBV infection

  2024cites this paper
• Identification and validation of ion channels-related mRNA prognostic signature for glioblastomas

  2024cites this paper
• Immune microenvironment of cancer bone metastasis.

  2024cites this paper
• MDSC: a new potential breakthrough in CAR-T therapy for solid tumors

  2024cites this paper
• Tryptophan-immunoadsorption plasmapheresis regulates polymorphonuclear-myeloid-derived suppressor cells and pro-inflammatory cytokines.

  2024cites this paper
• Insights into CSF-1R Expression in the Tumor Microenvironment

  2024cites this paper
• Genetics and biology of pancreatic ductal adenocarcinoma

  2024cites this paper
• Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma

  2024cites this paper
• Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy

  2024cites this paper
• Upregulation of HSD11B1 promotes cortisol production and inhibits NK cell activation in pancreatic adenocarcinoma.

  2024cites this paper
• Therapeutic advantage of combinatorial CAR T cell and chemo-therapies.

  2024cites this paper
• Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment

  2024cites this paper
• Role of T cells in liver metastasis

  2024cites this paper
• Myeloid-derived suppressor cells in cancer: Current knowledge and future perspectives.

  2024cites this paper
• CD94 deficiency or blockade unleashes the anti-tumor immunity in mice and humanized murine models.

  2024cites this paper
• Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects

  2024cites this paper
• A new target of radiotherapy combined with immunotherapy: regulatory T cells

  2024cites this paper
• Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulation

  2024influential citation
• Tumor immunity: A brief overview of tumor‑infiltrating immune cells and research advances into tumor‑infiltrating lymphocytes in gynecological malignancies (Review)

  2024influential citation
• Chemical immunology: Recent advances in tool development and applications.

  2024cites this paper
• Myeloid-Derived Suppressor Cells Promote Allograft Survival By Suppressing Treg Dysfunction in High-Risk Corneal Transplantation.

  2024cites this paper
• Regulatory T cells as crucial trigger and potential target for hyperprogressive disease subsequent to PD-1/PD-L1 blockade for cancer treatment.

  2024cites this paper
• IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma

  2024cites this paper
• Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review)

  2024cites this paper
• Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway

  2024cites this paper
• Immune Cell Profiling Reveals a Common Pattern in Premetastatic Niche Formation Across Various Cancer Types

  2024cites this paper
• Current and future immunotherapeutic approaches in pancreatic cancer treatment

  2024cites this paper
• The role of myeloid-derived immunosuppressive cells in cardiovascular disease.

  2023cites this paper
• The role of myeloid derived suppressor cells in musculoskeletal disorders

  2023influential citation
• Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

  2023cites this paper
• LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells

  2023cites this paper